Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 study (Q35953518)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 study |
scientific article |
Statements
1 reference
Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 study (English)
1 reference
John C Byrd
1 reference
Nyla A Heerema
1 reference
Kristie A Blum
1 reference
Jeffrey A Jones
1 reference
Michael R Grever
1 reference
Samantha M Jaglowski
1 reference
Danelle F James
1 reference
Jennifer A Woyach
1 reference
Leslie A Andritsos
1 reference
Gerard Lozanski
1 reference
Kami J Maddocks
1 reference
Amy S Ruppert
1 reference
Veena Nagar
1 reference
Kelly Smucker
1 reference
Joseph M Flynn
1 reference
Mona Stefanos
1 reference
Brian Munneke
1 reference
Jamie-Sue West
1 reference
Jutta K Neuenburg
1 reference
Nathan Hall
1 reference
Amy J Johnson
1 reference
26 June 2015
1 reference
1 reference
842-850
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference